For Immediate Release
Commack, NY, March 28, 2016 – Gemini Pharmaceuticals Inc., a global manufacturer of science based dietary and nutritional supplements for the past 33 years, announces the addition of Scott Koleda to its sales team. In his new role, he will be Director of New Business Development / Nutritional Sales.
Scott has over 8 years of experience selling and marketing contract manufacturing services to the dietary supplements industry. He was previously with NutraScience Labs LLC, Farmingdale, NY. During his career, Scott has worked with nutritional companies in every segment of the industry.
“Gemini offers me a new and exciting opportunity. They have developed a solid reputation in the industry for producing the highest quality dietary supplements. I am pleased to be part of the Gemini team” commented Scott.
“We are very excited to have Scott as a member of our sales force. His primary focus will be to expand our service sales to the brand owner/ own label distributor segment of the dietary supplement industry. Scott has established close relationships with many brand owners which resulted in significant growth for his former company. His background and experience will complement our existing sales team and will be a great asset to Gemini as we are committed to aggressively exceed our consistent year-over-year double-digit growth” offers Mike Finamore, CEO of Gemini Pharmaceuticals Inc.
About Gemini Pharmaceuticals Inc.:
Gemini Pharmaceuticals Inc. is a global manufacturer of science based dietary and nutritional supplements. With over 30 years of experience, Gemini has grown to be a world class manufacturer of solid dosage product with production exceeding 13 billion tablets / capsules per year. The quality of the operation has been recognized by the achievement of both NSF and TGA registrations and the issuance of a Foreign Site Reference Number by Health Canada. Gemini also produces its products in compliance with both Kosher and Halal requirements. For additional information about Gemini Pharmaceuticals please see www.geminipharm.com or contact Mark Jost at mjost@geminipharm.com
Media Contact: Mark Jost, 631-543-3334; mjost@geminipharm.com
